Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Alivus Life Sciences Ltd. Share Price
Day's Range
Low
₹1,403.40
High
₹1,523.20
Price Summary
| Previous Close | ₹1,480.60 |
|---|---|
| Day's Range | ₹1,403.40 - ₹1,523.20 |
| Open | ₹1,497.20 |
| 52 Week Range | ₹819.00 - ₹1,546.00 |
| Volume | 15,82,226 |
| Market Cap | ₹0.02 |
| Previous Close | ₹1,480.55 |
|---|---|
| Day's Range | ₹1,402.10 - ₹1,521.75 |
| Open | ₹1,495.15 |
| 52 Week Range | ₹830.00 - ₹1,532.95 |
| Volume | 66,972 |
| Market Cap | ₹0.02 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 23,426.44 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.33 |
| Price/Earning (TTM) | 27.49 |
| TTM EPS (₹) | 54.47 |
| P/E Ratio | 21.18 |
| Book Value(₹) | 5.07 |
| PAT Margin (%) | 21.89 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 24.61 |
| Trade Value ( ₹ in Lacs) | 991.55 |
|---|---|
| Market Cap (₹ in Mn) | 0.02 |
| Dividend Yield(%) | 0.33 |
| Price/Earning (TTM) | 27.49 |
| TTM EPS (₹) | 54.47 |
| P/E Ratio | 21.18 |
| Book Value(₹) | 5.07 |
| PAT Margin (%) | 21.89 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 24.61 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5879.8 | 23868.84 |
| Expenses | N/A | N/A |
| PBT | 1741.37 | 6541.31 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1300.26 | 4856.27 |
About Alivus Life Sciences Ltd.
| Founded | 2011 |
|---|---|
| Managing Director | Yasir Rawjee |
| NSE Symbol | ALIVUS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,37,962.61 | 1,860.00 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,69,450.61 | 10,305.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,79,455.65 | 4,741.00 | 3,532.60 - 3,532.60 |
| Laurus Labs Ltd. | 1,26,703.22 | 2,335.00 | 917.95 - 917.95 |
| Lenskart Solutions Ltd. | 1,24,984.87 | 726.90 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,20,190.31 | 8,445.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,19,341.36 | 1,195.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,13,663.75 | 1,371.20 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,13,245.71 | 1,409.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,03,880.84 | 2,540.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Alivus Life Sciences informs about newspaper publication
Granules India informs about transcript of conference call
Pursuant to regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Granules India has informed that the transcript of the earnings conference call of the Company for the Q2 and half year of FY27 is enclosed with this letter.
The above information is a part of company’s filings submitted to BSE.
Mercury Laboratories submits newspaper advertisement
Granules India informs about change in corporate office address
Granules India has informed that the Registrar and Share Transfer Agent (RTA) of the Company - KFin Technologies has informed the Company regarding the change in their existing Corporate Office address to new address with effect from December 01, 2026, as details enclosed.
The above information is a part of company’s filings submitted to BSE.
Mercury Laboratories informs about newspaper publication
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Alivus Life Sciences Ltd. is ₹1,480.60 as of 2026-11-06.
The market capitalisation of Alivus Life Sciences Ltd. is ₹18,411.28 as of 2026-11-05.
The 1-year return of Alivus Life Sciences Ltd. is 576.65% as of 2026-11-06.
The P/E ratio of Alivus Life Sciences Ltd. is 21.18 as of 2026-11-06.
The 52-week high and low of Alivus Life Sciences Ltd. are ₹1,546.00 and ₹819.00, respectively, as of 2026-11-06.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
